转甲状腺素蛋白心脏淀粉样变性的超声表型与预后
研究纳入1240例ATTR-CM患者(766例野生型,474例遗传型,其中314例V122I、127例T60A),进行前瞻性协议化超声评估与生存分析。V122I型收缩与舒张功能最差,T60A型最轻,野生型居中;每搏量指数、右房面积指数、纵向应变和E/e'均独立与死亡率相关,重度主动脉瓣狭窄也独立与预后相关(中位生存22 vs. 53个月,P=0.001)。
要点
- 不同基因型ATTR-CM超声严重程度不同,V122I最重、T60A最轻。
- 每搏量指数、右房面积指数、纵向应变和E/e'独立预测死亡。
- 合并重度主动脉瓣狭窄者生存显著缩短(中位22 vs. 53个月)。
核心结论
- 三种基因型ATTR-CM呈现不同严重程度的超声表型,收缩与舒张功能均独立与死亡率相关。
- 重度主动脉瓣狭窄独立与患者生存显著缩短相关。
研究设计与样本
- 研究纳入2000至2019年间1240例ATTR-CM患者,均接受前瞻性协议化完整超声评估与生存随访。
- 队列包括766例野生型wtATTR-CM和474例遗传型hATTR-CM,其中314例为V122I变异、127例为T60A变异。
主要发现
- 诊断时V122I-hATTR-CM患者在所有超声参数上收缩与舒张功能障碍最严重,T60A-hATTR-CM最轻,wtATTR-CM居中。
- 每搏量指数、右房面积指数、纵向应变和E/e'均独立与死亡率相关(P均<0.05)。
- 重度主动脉瓣狭窄独立与预后相关,中位生存22 vs. 53个月(P=0.001)。
关键数值与推荐
- 每搏量指数、右房面积指数、纵向应变和E/e'独立与死亡率相关(P<0.05)。
- 重度主动脉瓣狭窄者中位生存22个月,无重度AS者53个月(P=0.001)。
临床怎么用
- 对ATTR-CM患者应常规评估每搏量指数、右房面积指数、纵向应变和E/e'以辅助风险分层。
- 合并重度主动脉瓣狭窄提示预后更差,需加强随访与综合管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Transthyretin amyloidosis cardiomyopathy (ATTR-CM) is an increasingly recognized cause of heart failure. We sought to characterize the structural and functional echocardiographic phenotype across the spectrum of wild-type (wtATTR-CM) and hereditary (hATTR-CM) transthyretin cardiomyopathy and the echocardiographic features predicting prognosis. METHODS AND RESULTS: We studied 1240 patients with ATTR-CM who underwent prospective protocolized evaluations comprising full echocardiographic assessment and survival between 2000 and 2019, comprising 766 with wtATTR-CM and 474 with hATTR-CM, of whom 314 had the V122I variant and 127 the T60A variant. At diagnosis, patients with V122I-hATTR-CM had the most severe degree of systolic and diastolic dysfunction across all echocardiographic parameters and patients with T60AhATTR-CM the least; patients with wtATTR-CM had intermediate features. Stroke volume index, right atrial area index, longitudinal strain, and E/e' were all independently associated with mortality (P < 0.05 for all). Severe aortic stenosis (AS) was also independently associated with prognosis, conferring a significantly shorter survival (median survival 22 vs. 53 months, P = 0.001). CONCLUSION: The three distinct genotypes present with varying degrees of severity. Echocardiography indicates a complex pathophysiology in which both systolic and diastolic function are independently associated with mortality. The presence of severe AS was independently associated with significantly reduced patient survival.
引用
- Chacko L, Martone R, Bandera F, et al. Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis. Eur Heart J. 2020. PMID: 31950987. doi:10.1093/eurheartj/ehz905
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。